Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126269911 | 12626991 | 1 | I | 20160727 | 20160805 | 20160805 | EXP | CN-MYLANLABS-2016M1031789 | MYLAN | JING X-M, ZHANG Z-H, WU P, ZHANG S-C, REN Y-R, XIONG Z-J, ET AL. EFFICACY AND TOLERANCE OF PEGASPARGASE, GEMCITABINE AND OXALIPLATIN WITH SANDWICHED RADIOTHERAPY IN THE TREATMENT OF NEWLY-DIAGNOSED EXTRANODAL NATURE KILLER (NK)/T CELL LYMPHOMA. LEUK-RES 2016;47:26-31. | 0.00 | Y | 0.00000 | 20160805 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126269911 | 12626991 | 1 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1000 MG/M2 ON DAY 1 AND 8 | 200145 | INJECTION | |||||||||
| 126269911 | 12626991 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 130 MG/M2 ON DAY 1 | 0 | INJECTION | |||||||||
| 126269911 | 12626991 | 3 | SS | PEGASPARGASE | PEGASPARGASE | 1 | Intramuscular | 2500 IU/M2 ON DAY 0 OR 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126269911 | 12626991 | 1 | Angiocentric lymphoma |
| 126269911 | 12626991 | 2 | Angiocentric lymphoma |
| 126269911 | 12626991 | 3 | Angiocentric lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126269911 | 12626991 | OT |
| 126269911 | 12626991 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126269911 | 12626991 | Cerebral haemorrhage | |
| 126269911 | 12626991 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |